SEC Comment Letter for Sientra, Inc. (CIK 0001551693) — May 19, 2022
Sientra, Inc. (CIK 0001551693)
Date: May 19, 2022 · CIK: 0001551693 · Accession: 0000000000-22-005548
AI Filing Summary & Sentiment
File numbers found in text: 333-264888
Letter
United States securities and exchange commission logo May 19, 2022 Ronald Menezes Chief Executive Officer Sientra, Inc. 420 South Fairview Avenue, Suite 200 Santa Barbara, CA 93117 Re:Sientra, Inc. Registration Statement on Form S-3 Filed May 12, 2022 File No. 333-264888 Dear Mr. Menezes: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Patrick O'Malley, Esq.
Show Raw Text
United States securities and exchange commission logo
May 19, 2022
Ronald Menezes
Chief Executive Officer
Sientra, Inc.
420 South Fairview Avenue, Suite 200
Santa Barbara, CA 93117
Re:Sientra, Inc.
Registration Statement on Form S-3
Filed May 12, 2022
File No. 333-264888
Dear Mr. Menezes:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Patrick O'Malley, Esq.